Evidence map›Paper›PMID 30478038›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Interplay of the Norrin and Wnt7a/Wnt7b signaling systems in blood-brain barrier and blood-retina barrier development and maintenance.

Yanshu Wang, Chris Cho, John Williams, Philip M Smallwood, Chi Zhang, Harald J Junge, Jeremy Nathans

Erratum issuedAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 110 papers.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 166 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yanshu WangDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Chris ChoDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
John WilliamsDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Philip M SmallwoodDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Chi ZhangDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309.
Harald J JungeDepartment of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309.
Jeremy NathansDepartment of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205; jnathans@jhmi.edu.ORCID 0000-0001-8106-5460
Howard Hughes Medical Institute · USUniversity of Colorado Boulder · USJohns Hopkins University · US

Funding

The control of retinal vascular development by Norrin and Frizzled4R01EY018637 · NEI · JOHNS HOPKINS UNIVERSITY · PI NATHANS, JEREMY · 2008 to 2021
$5.5M
Norrin Signaling in the Retina: Regulation of the Blood-Retina BarrierR01EY024261 · NEI · UNIVERSITY OF MINNESOTA · PI Harald Junge · 2014 to 2026
$4.7M
Howard Hughes Medical InstituteNEI NIH HHS R01 EY018637NEI NIH HHS R01 EY024261
6 · The paper itself

Abstract

β-Catenin signaling controls the development and maintenance of the blood-brain barrier (BBB) and the blood-retina barrier (BRB), but the division of labor and degree of redundancy between the two principal ligand-receptor systems-the Norrin and Wnt7a/Wnt7b systems-are incompletely defined. Here, we present a loss-of-function genetic analysis of postnatal BBB and BRB maintenance in mice that shows striking threshold and partial redundancy effects. In particular, the combined loss of Wnt7a and Norrin or Wnt7a and Frizzled4 (Fz4) leads to anatomically localized BBB defects that are far more severe than observed with loss of Wnt7a, Norrin, or Fz4 alone. In the cerebellum, selective loss of Wnt7a in glia combined with ubiquitous loss of Norrin recapitulates the phenotype observed with ubiquitous loss of both Wnt7a and Norrin, implying that glia are the source of Wnt7a in the cerebellum. Tspan12, a coactivator of Norrin signaling in the retina, is also active in BBB maintenance but is less potent than Norrin, consistent with a model in which Tspan12 enhances the amplitude of the Norrin signal in vascular endothelial cells. Finally, in the context of a partially impaired Norrin system, the retina reveals a small contribution to BRB development from the Wnt7a/Wnt7b system. Taken together, these experiments define the extent of CNS region-specific cooperation for several components of the Norrin and Wnt7a/Wnt7b systems, and they reveal substantial regional heterogeneity in the extent to which partially redundant ligands, receptors, and coactivators maintain the BBB and BRB.

Indexed as

Animalsbeta CateninBlood-Brain BarrierBlood-Retinal BarrierCell Culture TechniquesEye ProteinsFrizzled ReceptorsMiceMice, KnockoutModels, BiologicalModels, NeurologicalNerve Tissue ProteinsProto-Oncogene ProteinsSignal TransductionTetraspaninsWnt Proteinsbeta CateninCTNNB1 protein, mouseEye ProteinsFrizzled ReceptorsFzd4 protein, mouseNdph protein, mouseNerve Tissue ProteinsProto-Oncogene ProteinsTetraspaninsTspan12 protein, mouseWnt7a protein, mouseWnt7b protein, mouseWnt Proteinscentral nervous systemmouse geneticsvascular endothelial cellsβ-catenin signaling

Identifiers

PMID30478038
PMCPMC6294914
OpenAlexW2902651045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.